MEDICAMEQ.BO
Medicamen Biotech Limited
BSEINREQUITY
Healthcare
DELAYED
Last price
246.10
▲ 1.40 (0.57%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
243.00
Prev close
244.70
Day high
249.00
Day low
236.65
Volume
5.00K
Market cap
$3.34B
P/E (TTM)
34.13
52W range
210.10 – 454.00
Day trading desk
Gap from prior close
-0.69%
Prior close 244.70
VWAP
246.42
-0.13% from price
Relative volume
1.89×
Unusually busy
Session range
5.22%
236.65 – 249.00
Position in range
77%
Near session high
ATR (14D)
11.65
4.73% of price
Prior day high
245.80
PDH
Prior day low
229.00
PDL
Bid / ask spread
—
Quote not published
Session volume
4.97K
Avg 2.63K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+2.22%
+3.6%
1M
+3.27%
-0.5%
3M
-9.29%
-12.4%
6M
-26.31%
-37.4%
YTD
-32.21%
-44.5%
1Y
-30.54%
-50.5%
3Y
-69.55%
-143.7%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on MEDICAMEQ.BO open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
9.81M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 23, 25 | Bansal (Sanjay) Promoter |
SELL | 100.00K | — | Direct |
| Dec 12, 24 | Madan (Geetika) UNREPORTED |
SELL | 2.00K | $13.49K | Direct |
| Dec 6, 24 | Madan (Geetika) UNREPORTED |
SELL | 313 | $2.26K | Direct |
| Nov 25, 24 | Madan (Geetika) UNREPORTED |
SELL | 3.00K | $15.97K | Direct |
| Sep 16, 24 | Madan (Geetika) UNREPORTED |
SELL | 1.49K | $8.46K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
Bansal (Sanjay) |
Promoter | 102.81K | Sale |
Madan (Geetika) |
UNREPORTED | 24.69K | Sale |
Fundamentals
Market cap$3.34B
Enterprise value$4.00B
Revenue (TTM)$2.06B
Gross profit$1.06B
EBITDA$228.94M
Net income$96.07M
EPS (TTM)$7.21
Free cash flow—
Total cash$312.64M
Total debt$477.84M
Book value / share$234.32
Shares outstanding13.56M
Float4.71M
Short % of float—
Dividend yield0.41%
Beta (5Y)0.72
Valuation & profitability ratios
Trailing P/E34.13
Forward P/E20.31
PEG ratio—
Price / sales—
Price / book1.05
EV / revenue1.94
EV / EBITDA17.47
Gross margin51.40%
Operating margin6.97%
Profit margin4.66%
Return on equity—
Return on assets—
Debt / equity17.34
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $1.98B | $1.63B | $1.79B | $1.41B | — | +21.7% |
| Operating revenue | $1.98B | $1.63B | $1.79B | $1.41B | — | +21.7% |
| Cost of revenue | $1.02B | $846.18M | $1.10B | $859.91M | — | +20.3% |
| Gross profit | $959.98M | $779.29M | $697.58M | $548.76M | — | +23.2% |
| Selling, general & admin | — | $132.65M | $142.60M | $82.75M | $77.20M | — |
| Total operating expense | $836.29M | $711.37M | $523.54M | $359.86M | — | +17.6% |
| Operating income | $123.69M | $67.92M | $174.04M | $188.90M | — | +82.1% |
| Net interest income | -$34.97M | -$31.56M | -$49.48M | -$26.71M | — | -10.8% |
| Pre-tax income | $119.84M | $98.80M | $130.76M | $170.45M | — | +21.3% |
| Tax provision | $21.88M | $33.24M | $35.82M | $23.16M | — | -34.2% |
| Net income | $96.41M | $71.08M | $109.31M | $148.44M | — | +35.6% |
| Net income to common | $96.41M | $71.08M | $109.31M | $148.44M | — | +35.6% |
| Basic EPS | — | 5.16 | 8.63 | 11.73 | 12.19 | — |
| Diluted EPS | — | 5.16 | 8.63 | 11.73 | 12.19 | — |
| EBIT | $154.82M | $130.36M | $174.73M | $199.68M | — | +18.8% |
| EBITDA | $227.00M | $201.02M | $245.66M | $263.34M | — | +12.9% |
| Basic shares | — | 12.71M | 12.66M | 12.65M | 12.22M | — |
| Diluted shares | — | 12.71M | 12.66M | 12.65M | 12.22M | — |
| Line item | 2026 | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $312.64M | $37.59M | $147.86M | $207.79M | — | +731.6% |
| Cash & short-term investments | $312.64M | $37.59M | $147.86M | $207.79M | — | +731.6% |
| Accounts receivable | $818.28M | $689.00M | $552.59M | $652.58M | — | +18.8% |
| Inventory | $700.79M | $621.37M | $593.75M | $450.57M | — | +12.8% |
| Total current assets | $2.24B | $1.65B | $1.60B | $1.63B | — | +36.0% |
| Property, plant & equipment | $840.92M | $863.62M | $909.52M | $917.59M | — | -2.6% |
| Goodwill & intangibles | $5.72M | $7.42M | $8.98M | $8.98M | — | -23.0% |
| Total assets | $3.72B | $2.97B | $2.95B | $2.79B | — | +25.2% |
| Total current liabilities | $879.20M | $781.62M | $845.55M | $825.74M | — | +12.5% |
| Current debt | $416.31M | $300.40M | $298.56M | $248.39M | — | +38.6% |
| Long-term debt | $61.53M | $37.34M | $12.55M | $8.70M | — | +64.8% |
| Total debt | $477.84M | $337.74M | $311.12M | $257.09M | — | +41.5% |
| Total liabilities | $964.38M | $840.98M | $875.67M | $851.03M | — | +14.7% |
| Retained earnings | — | $963.08M | $907.67M | $825.38M | $687.82M | — |
| Shareholder equity | $2.76B | $2.12B | $2.05B | $1.93B | — | +30.1% |
| Working capital | $1.36B | $863.88M | $750.38M | $807.89M | — | +57.2% |
| Net tangible assets | $2.75B | $2.11B | $2.04B | $1.93B | — | +30.3% |
| Shares issued | 13.56M | 12.71M | 12.71M | 12.65M | — | +6.7% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Net income | $97.96M | $65.56M | $94.94M | $147.28M | +49.4% |
| Depreciation & amortisation | $72.19M | $69.10M | $70.93M | $63.67M | +4.5% |
| Change in working capital | -$521.34M | -$262.48M | -$275.21M | -$287.76M | -98.6% |
| Operating cash flow | -$331.72M | -$81.59M | -$67.44M | -$62.93M | -306.6% |
| Capital expenditure | -$47.78M | -$21.89M | -$62.87M | -$66.01M | -118.3% |
| Investing cash flow | -$30.39M | -$13.97M | -$55.63M | -$58.80M | -117.5% |
| Dividends paid | -$13.56M | -$12.71M | -$12.65M | -$12.65M | -6.7% |
| Financing cash flow | $637.16M | -$14.71M | $63.13M | $291.27M | +4,432.6% |
| Free cash flow | -$379.50M | -$103.47M | -$130.31M | -$128.94M | -266.8% |
| End cash position | $312.64M | $37.59M | $147.86M | $207.79M | +731.6% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $606.47M | $469.08M | $471.70M | $430.45M | $296.13M | +29.3% |
| Operating revenue | $606.47M | $469.08M | $471.70M | $430.45M | $296.13M | +29.3% |
| Cost of revenue | $321.96M | $237.10M | $231.53M | $227.13M | $137.65M | +35.8% |
| Gross profit | $284.50M | $231.99M | $240.17M | $203.32M | $158.48M | +22.6% |
| Total operating expense | $247.43M | $206.51M | $207.18M | $175.18M | $179.35M | +19.8% |
| Operating income | $37.08M | $25.48M | $32.99M | $28.14M | -$20.87M | +45.5% |
| Net interest income | -$3.83M | -$9.72M | -$9.89M | -$11.53M | -$6.50M | +60.6% |
| Pre-tax income | $50.60M | $21.11M | $26.83M | $21.31M | $24.90M | +139.7% |
| Tax provision | $6.13M | $4.76M | $5.69M | $5.30M | $6.27M | +28.7% |
| Net income | $38.57M | $16.35M | $26.67M | $21.53M | $24.16M | +136.0% |
| Net income to common | $38.57M | $16.35M | $26.67M | $21.53M | $24.16M | +136.0% |
| Basic EPS | 3.28 | 1.21 | 1.56 | 1.18 | 1.47 | +171.1% |
| Diluted EPS | 3.28 | 1.21 | 1.56 | 1.18 | 1.47 | +171.1% |
| EBIT | $54.43M | $30.83M | $36.72M | $32.84M | $31.40M | +76.5% |
| EBITDA | $71.76M | $49.10M | $55.28M | $50.86M | $36.19M | +46.1% |
| Basic shares | 11.76M | 13.51M | 17.09M | 13.56M | 16.44M | -13.0% |
| Diluted shares | 11.76M | 13.51M | 17.09M | 13.56M | 16.44M | -13.0% |
| Line item | 2026-03-31 | 2025-09-30 | 2025-03-31 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $312.64M | $436.79M | $37.59M | -28.4% |
| Cash & short-term investments | $312.64M | $436.79M | $37.59M | -28.4% |
| Accounts receivable | $818.28M | $775.71M | $689.00M | +5.5% |
| Inventory | $700.79M | $687.68M | $621.37M | +1.9% |
| Total current assets | $2.24B | $2.23B | $1.65B | +0.1% |
| Property, plant & equipment | $840.92M | $849.76M | $863.62M | -1.0% |
| Goodwill & intangibles | $5.72M | $6.59M | $7.42M | -13.2% |
| Total assets | $3.72B | $3.67B | $2.97B | +1.3% |
| Total current liabilities | $879.20M | $855.86M | $781.62M | +2.7% |
| Current debt | $416.31M | $350.31M | $300.40M | +18.8% |
| Long-term debt | $61.53M | $36.17M | $37.34M | +70.1% |
| Total debt | $477.84M | $386.49M | $337.74M | +23.6% |
| Total liabilities | $964.38M | $916.99M | $840.98M | +5.2% |
| Retained earnings | — | — | $963.08M | — |
| Shareholder equity | $2.76B | $2.75B | $2.12B | +0.1% |
| Working capital | $1.36B | $1.38B | $863.88M | -1.5% |
| Net tangible assets | $2.75B | $2.75B | $2.11B | +0.1% |
| Shares issued | 13.56M | 13.56M | 12.71M | 0.0% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Mar 2020 | 3.50 | 1.20 | -65.7% |
| Dec 2019 | 2.72 | 3.05 | +12.1% |
| Sep 2019 | — | 3.18 | — |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders62.97%
Held by institutions0.00%
Institutions holding0
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
236.24
+4.18% from price
SMA 20
237.74
+3.52% from price
SMA 50
239.25
+2.86% from price
SMA 100
249.10
-1.21% from price
SMA 200
301.34
-18.33% from price
EMA 12
237.48
+3.63% from price
EMA 26
238.74
+3.08% from price
EMA 50
242.54
+1.47% from price
RSI (14)
55.3
Neutral
MACD (12,26,9)
-1.26
Hist 0.71
ATR (14)
11.65
4.73% of price
Realised vol 30D
42.1%
Annualised
Bollinger upper
250.39
20, 2σ
Bollinger lower
225.09
20, 2σ
50 / 200 cross
Death
239.25 vs 301.34
Trend bias
Below 200
-18.33%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.54
Less volatile than market
Correlation to SPY
0.15
Largely independent
Realised vol 30D
42.1%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-46.8%
Peak to trough
Max drawdown 5Y
-81.5%
Peak to trough
ATR 14
11.65
4.73% of price
Beta (reported)
0.72
5Y monthly, from filing
Dividends & splits
Forward rate$1.00 / yr
Forward yield0.41%
5-year avg yield0.20%
Payout ratio13.85%
Ex-dividend dateSep 18, 2026
Next pay date—
Last split—
Split date—
Headlines
HP exec reveals the Gen Z ‘superpower’ that he says helps young employees build ‘a healthy relationship with work’
Moneywise · 4m ago
/R E P E A T -- Media Advisory - Minister Miller will announce major funding for a cultural organization in Montréal/
CNW Group · 4m ago
The Roth Conversion Mistake Too Many Pre-Retirees Make
Motley Fool · 8m ago
2 Dividend Stocks to Buy and Never Sell
Motley Fool · 14m ago
'New season, new trim': Man City star Haaland chops off flowing locks
AFP · 15m ago
Got $2M saved? You should (probably) retire immediately. Don't sacrifice it all for nothing
Moneywise · 19m ago
Another DeFi Hack: Term Labs Loses $8.5 Million in Governance Exploit
BeInCrypto · 29m ago
Is Wolfspeed Stock a Buy on the Latest Dip?
Motley Fool · 29m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.